Ausgabe 12/2018
Inhalt (21 Artikel)
Melanoma treatment: from conventional to nanotechnology
Harshita Mishra, Pawan K. Mishra, Adam Ekielski, Manu Jaggi, Zeenat Iqbal, Sushama Talegaonkar
The roles of PKCs in regulating autophagy
Tianyi Wang, Conghe Liu, Lili Jia
MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance
Maria Luisa Gasparri, Zein Mersini Besharat, Ammad Ahmad Farooqi, Sumbul Khalid, Katayoun Taghavi, Raad Aris Besharat, Claudia Sabato, Andrea Papadia, Pierluigi Benedetti Panici, Michael David Mueller, Elisabetta Ferretti
The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research
Beatriz Dal Pont Duarte, Diego Bonatto
Role of ferroptosis in hepatocellular carcinoma
Jianhua Nie, Binlin Lin, Meng Zhou, Li Wu, Tongsen Zheng
The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers
Hirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, Masami Suganuma
MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1
Xin-Long Ma, Feng Shang, Wei Ni, Jin Zhu, Bin Luo, Yu-Qi Zhang
Presence and activity of HPV in primary lung cancer
Talita Helena Araujo de Oliveira, Carolina Medeiros do Amaral, Bianca de França São Marcos, Kamylla Conceição Gomes Nascimento, Ana Carine de Miranda Rios, Dafne Carolina Alves Quixabeira, Maria Tereza Cartaxo Muniz, Jacinto da Costa Silva Neto, Antonio Carlos de Freitas
Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma
Anda J. Stroese, Hansjoerg Ullerich, Gabriele Koehler, Verena Raetzel, Norbert Senninger, Sameer A. Dhayat
Modified AJCC staging of gastric neuroendocrine carcinoma based on T staging can improve the capacity of prognosis assessment
Jian-Wei Xie, Ping Li, Jia-Bin Wang, Jian-Xian Lin, Jun Lu, Qi-Yue Chen, Ying-Hong Yang, De-Yong Kang, Chao-Hui Zheng, Chang-Ming Huang
Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway
Dolores Fernández, Macarena Guereño, María Amparo Lago Huvelle, Magalí Cercato, María Giselle Peters
The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma
Max Michael Traeger, Jan Rehkaemper, Hansjoerg Ullerich, Konrad Steinestel, Eva Wardelmann, Norbert Senninger, Sameer Abdallah Dhayat
Progress in gene therapy using oncolytic vaccinia virus as vectors
Xue Yang, Biao Huang, Lili Deng, Zhigang Hu
Analysis of unexpected small cell lung cancer following surgery as the primary treatment
Haitang Yang, Jianlin Xu, Feng Yao, Shunqing Liang, Heng Zhao
Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer
Gary Altwerger, Esther B. Florsheim, Gulden Menderes, Jonathan Black, Carlton Schwab, Gregory M. Gressel, Wendelin K. Nelson, Nina Carusillo, Terri Passante, Gloria Huang, Babak Litkouhi, Masoud Azodi, Dan-Arin Silasi, Alessandro Santin, Peter E. Schwartz, Elena S. Ratner
Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer
Jan A. Stratmann, Sebastian Michels, Sofia Hornetz, Daniel C. Christoph, Sandra Sackmann, Werner Spengler, Helge Bischoff, Monica Schäfer, Jürgen Alt, Annette Müller, Eckart Laack, Martin Kimmich, Frank Griesinger, Martin Sebastian
Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation
Xinyu Li, Lei Huang, Xisheng Leng
Kaposiform hemangioendothelioma without cutaneous involvement
Yi Ji, Siyuan Chen, Lizhi Li, Kaiying Yang, Chunchao Xia, Li Li, Gang Yang, Feiteng Kong, Guoyan Lu, Xingtao Liu
Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma
Turki M. Almuhaimid, Won Sub Lim, Jong-Lyel Roh, Jungsu S. Oh, Jae Seung Kim, Soo-Jong Kim, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
Sandra Bonache, Irene Esteban, Alejandro Moles-Fernández, Anna Tenés, Laura Duran-Lozano, Gemma Montalban, Vanessa Bach, Estela Carrasco, Neus Gadea, Adrià López-Fernández, Sara Torres-Esquius, Francesco Mancuso, Ginevra Caratú, Ana Vivancos, Noemí Tuset, Judith Balmaña, Sara Gutiérrez-Enríquez, Orland Diez